Slade assists hospitals with clinical trials by providing compounding services from our TGA-licenced facilities. Currently supporting over 200 clinical trials, our experience covers Phase 1-4 studies, primarily in oncology and haematology.
Slade’s clinical trials service includes national clinical trial co-ordination among its TGA-licenced compounding facilities to ensure relevant criteria is met for the compounding of investigational products. Each compounding facility has dedicated trials staff who have complete oversight over the management and segregated storage of clinical trial drugs in validated and monitored equipment.
